Sectors

ASBP
Aspire Biopharma Holdings, Inc.
8.88
2 x 6.40
2 x 10.88
bid
ask
+
0.37
4.35%
02:50 PM
timesize
Ytd68.18%
1y-61.39%
8.49
day range
8.98
0.11
52 week range
23.48
Open8.49Prev Close8.51Low8.49High8.98Mkt Cap12.45M
Vol23.64KAvg Vol275.00KEPS-6.65P/EN/AForward P/EN/A
Beta0.11Short RatioN/AInst. OwnN/ADividendN/ADiv YieldN/A
Ex Div DateN/AEarningN/A50-d Avg6.90200-d Avg3.821yr Est0.00
Income Statement
Total Revenue63.10K
Revenues (USD)63.10K
Cost of Revenue93.19K
Gross Profit-30.09K
Operating Expenses2.65M
Research and Development Expense233.48K
Selling, General and Administrative Expense2.19M
Operating Income-2.68M
Net Income-1.27M
Net Income Common Stock-1.27M
Net Income Common Stock (USD)-1.27M
Consolidated Income-1.27M
Earnings per Basic Share-1.22
Earnings per Basic Share (USD)-1.22
Earnings per Diluted Share-1.22
Earning Before Interest & Taxes (EBIT)-1.27M
Earning Before Interest & Taxes (USD)-1.27M
Weighted Average Shares1.04M
Weighted Average Shares Diluted1.04M
Balance Sheet
Cash and Equivalents12.17M
Cash and Equivalents (USD)12.17M
Current Assets13.47M
Total Assets13.54M
Current Liabilities1.69M
Total Liabilities1.78M
Accumulated Retained Earnings (Deficit)-31.75M
Shareholders Equity11.76M
Shareholders Equity (USD)11.76M
Assets Non-Current75.00K
Inventory288.45K
Liabilities Non-Current96.53K
Trade and Non-Trade Payables972.11K
Cash Flow
Net Cash Flow from Financing8.43M
Net Cash Flow / Change in Cash & Cash Equivalents6.31M
Issuance (Repayment) of Debt Securities -499.21K
Net Cash Flow from Operations-2.12M
Share Based Compensation144.09K